Authors say a personalized approach to hormone therapy use with regular reassessment of risks and benefits is needed.

Recent medical updates highlight the long-term health benefits of the universal hepatitis B birth dose, alongside FDA milestones including the approval of Optune Pax for pancreatic cancer and a ...

Long-term data from the phase 3 ALIGN trial reinforce the safety and efficacy of atrasentan for patients with immunoglobulin A nephropathy.

Following FDA feedback, PTC Therapeutics withdrew its application for ataluren, intended for the treatment of nonsense mutation Duchenne muscular dystrophy.

Likelihood of developing preeclampsia with severe features lower for patients with and without chronic hypertension.

HealthDay News — Pregnant patients who discontinue their antidepressant medication during pregnancy are more likely to experience a mental health emergency, according to a study presented at The ...

Statewide, 18 measles cases have been reported since December, according to the North Carolina Department of Health and Human Services. Nearly three-quarters of the cases (72%) involved people who ...

HealthDay News — In a major blow to vaccine development, the US Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot. Dr Vinay Prasad, the ...

Infigratinib is an investigational oral therapy designed to directly inhibit FGFR3 protein phosphorylation, addressing the underlying cause of achondroplasia.

HealthDay News — The Trump administration plans to take back about $600 million in public health funding from 4 Democrat-led states, saying the grants no longer match health priorities. The states ...

Optune Pax is a portable medical device that delivers TTFields non-invasively via wearable arrays to disrupt electrical processes essential for cancer cell division.

“BHA has remained in the food supply for decades despite being identified by the National Toxicology Program as ‘reasonably anticipated to be a human carcinogen’ based on animal studies,” U.S.